Related by context. Frequent words. (Click for all words.) 79 pertuzumab 76 Trastuzumab 74 Bevacizumab 74 Irinotecan 74 Oxaliplatin 74 Gemcitabine 74 bevacizumab Avastin 73 Nexavar ® 73 Everolimus 73 mTOR inhibitor 73 angiogenesis inhibitor 73 Herceptin trastuzumab 73 proteasome inhibitors 73 Erlotinib 72 BAY #-# 72 Carfilzomib 71 Alemtuzumab 71 Zolinza 71 Amrubicin 71 Taxotere ® 71 PARP inhibitor 71 Lenalidomide 71 Bortezomib 71 Apixaban 70 Hycamtin 70 Sorafenib 70 KRN# 70 Avastin bevacizumab 70 elotuzumab 70 Imatinib 70 tyrosine kinase inhibitor 70 ZD# [001] 70 IRESSA 70 Sym# 70 Elesclomol 70 temsirolimus 69 Doxorubicin 69 Anastrozole 69 Imprime PGG 69 Maraviroc 69 Azedra 69 Panitumumab 69 tipranavir 69 biologic therapy 69 tanespimycin 68 MEK inhibitor 68 Docetaxel 68 Lapatinib 68 Torisel 68 Pirfenidone 68 Jevtana 68 ATL# [001] 68 Phase III Clinical Trial 68 deforolimus 68 HER2 positive metastatic breast 68 Rituximab 68 Microspheres 68 LY# [003] 68 R sorafenib tablets 68 luteinizing hormone releasing 68 decitabine 68 Combination therapy 68 BMS # 68 Carboplatin 68 Natalizumab 68 chemotherapeutic drug 68 Treanda 68 Voreloxin 67 Monoclonal Antibody 67 PARP inhibitors 67 EZN 67 immunomodulator 67 CCX# 67 mycophenolate mofetil 67 metastatic hormone refractory 67 DAVANAT 67 tocilizumab 67 OncoVEX GM CSF 67 nucleoside analogue 67 Cladribine 67 DOXIL 67 drug conjugate 67 CR# vcMMAE 67 Cetuximab 67 Ofatumumab 67 GV# [001] 67 PLX# 67 anticancer therapy 67 GLPG# 67 IMC A# 67 Doxil 67 Rebif ® 67 calcineurin inhibitors 66 Gemzar ® 66 SCH # 66 Drug Candidate 66 CoFactor 66 fusion inhibitor 66 Icatibant 66 LY# [002] 66 atacicept